Today's Daily Dose brings you news about Applied Genetic's near-term catalyst; Centric Health's new contract; SIGA's $629 million, multi-year contract with BARDA; the FDA panel review date of Trevena's Oliceridine injection, and Xenon's agreement with Bausch Health related to epilepsy drug candidate.
from RTT - Biotech https://ift.tt/2MpkONO
via IFTTT
No comments:
Post a Comment